MRKS-Brand-Logo-Final-FullColor.png
Merakris Therapeutics Announces FDA Clearance for Part 2 of its Phase II Multicenter Investigational New Drug Study of Dermacyte® Liquid
05 sept. 2024 06h30 HE | Merakris Therapeutics
Part 2 of the Phase II multicenter clinical study for the investigational wound care drug, Dermacyte® Amniotic Wound Care Liquid, will begin late 2024.
Kane Logo Cropped TransBG.png
Kane Biotech Expands its Wound Care Portfolio with Patented Schultz Biofilm Wound Map
15 mai 2024 08h00 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, May 15, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces its intent to commercialize the patented assay...
MM Flex Image
Integra LifeSciences Launches MicroMatrix® Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex Cases
11 mars 2024 08h30 HE | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., March 11, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), today announced MicroMatrix® Flex is now available commercially in the U.S. MicroMatrix...
Kane Logo Cropped TransBG.png
Kane Biotech to Exhibit at Symposium on Advanced Wound Care Fall Forum
25 oct. 2023 07h45 HE | Kane Biotech Inc.
WINNIPEG, Manitoba, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces that it will be unveiling the new brand for its...
TIP_link_300x300.jpg
Skin Grafting System Market Size Worth $1.34Bn, Globally, by 2028 at 7.1% CAGR - Exclusive Report by The Insight Partners
29 avr. 2022 06h16 HE | The Insight Partners
New York, April 29, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Skin Grafting System Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product...
Logo.png
Wound Closure Devices Market to Surpass USD 22 Billion and Expected to Witness a CAGR of 7.40% by 2026 | DelveInsight
04 févr. 2022 13h00 HE | DelveInsight Business Research LLP
New York, USA, Feb. 04, 2022 (GLOBE NEWSWIRE) -- Wound Closure Devices Market to Surpass USD 22 Billion and Expected to Witness a CAGR of 7.40% by 2026 | DelveInsight As per DelveInsight...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A RESPECTED AND LEADING FIRM, Encourages PolarityTE, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – PTE
29 sept. 2021 16h08 HE | The Rosen Law Firm PA
NEW YORK, Sept. 29, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of...
RenovaCare Clinical Trial to Start at U.S. Burn Centers
RenovaCare Clinical Trial to Start at U.S. Burn Centers
07 juin 2021 08h30 HE | RenovaCare, Inc.
ROSELAND, N.J., June 07, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), today announced that it is initiating a clinical trial at four burn centers in the United...
Merakris Therapeutics, Inc. Announces FDA Clearance for Dermacyte® Liquid Clinical Trial
25 mai 2021 09h00 HE | Merakris Therapeutics
RESEARCH TRIANGLE PARK, N.C., May 25, 2021 (GLOBE NEWSWIRE) -- Merakris Therapeutics, Inc. (Merakris) announced that it has received U.S. Food and Drug Administration (FDA) clearance for a Phase II...
RenovaCare CellMist™ and SkinGun™ System
RenovaCare to Present at H.C. Wainwright Global Life Sciences Conference March 9-10, 2021
25 févr. 2021 08h30 HE | RenovaCare, Inc.
ROSELAND, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for...